Home/Filings/4/0001847223-25-000007
4//SEC Filing

Kelly Julie 4

Accession 0001847223-25-000007

CIK 0001823608other

Filed

Nov 2, 7:00 PM ET

Accepted

Nov 3, 8:06 PM ET

Size

20.9 KB

Accession

0001847223-25-000007

Insider Transaction Report

Form 4
Period: 2025-10-30
Kelly Julie
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2025-10-30$13.75/sh+4,220$58,02523,470 total
  • Tax Payment

    Common Stock

    2025-10-30$27.56/sh2,048$56,43821,422 total
  • Tax Payment

    Common Stock

    2025-10-30$27.56/sh1,922$52,96623,460 total
  • Exercise/Conversion

    Common Stock

    2025-10-30$14.65/sh+3,960$58,01425,382 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2025-10-304,2200 total
    Exercise: $13.75From: 2017-01-01Exp: 2027-01-01Common Stock (4,220 underlying)
  • Exercise/Conversion

    Common Stock

    2025-10-30$12.00/sh+4,820$57,84021,590 total
  • Tax Payment

    Common Stock

    2025-10-30$27.56/sh2,340$64,48519,250 total
  • Sale

    Common Stock

    2025-10-31$27.34/sh6,697$183,10716,763 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2025-10-303,9600 total
    Exercise: $14.65From: 2018-01-01Exp: 2028-01-01Common Stock (3,960 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2025-10-304,8200 total
    Exercise: $12.00From: 2016-01-01Exp: 2026-01-01Common Stock (4,820 underlying)
  • Award

    Common Stock

    2025-11-01+2,31119,074 total
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.06 - $27.635 . The reporting person undertakes to provide to AMAL, any security holder of AMAL, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
  • [F2]The reported transaction involved the reporting person's receipt of a grant of 2,311 restricted stock units. The restricted stock units vest immediately upon grant, in consideration of the Company's termination of the stock option program and the Director's early exercise of all outstanding and vested stock options on October 30, 2025.

Issuer

Amalgamated Financial Corp.

CIK 0001823608

Entity typeother

Related Parties

1
  • filerCIK 0001847223

Filing Metadata

Form type
4
Filed
Nov 2, 7:00 PM ET
Accepted
Nov 3, 8:06 PM ET
Size
20.9 KB